| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |